Clinical Trials Directory

Trials / Completed

CompletedNCT02956083

The Effect of Tear Supplements on Contact Lens Comfort

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of the Incarnate Word · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this investigation is to determine if lipid based artificial tear supplementation has an impact on contact lens discomfort (CLD).

Detailed description

Contact lens discomfort (CLD) is the most common cause of discontinuing contact lens wear. Despite years of research and innovations in technology, CLD remains highly prevalent, and thus it is a major concern for patients and practitioners. Studies suggest that meibomian gland dysfunction (MGD) is a cause of CLD. Several lipid-based artificial tears have recently been designed to address dry eye associated with MGD. In this study, the investigators examine if the benefits of lipid based artificial tears extend to improving contact lens comfort. Studies have demonstrated some usefulness of non-lipid based tear supplements in the management of contact lens discomfort. However, the relief was moderate and short-term. To date, no study has examined the impact of lipid based artificial tears on contact lens discomfort. In this study, the investigators will address this gap in knowledge.

Conditions

Interventions

TypeNameDescription
OTHERSystane Balance eye dropsPropylene Glycol 0.6% Over the counter lipid based artificial tears.
OTHERSystane Contacts eye dropsHydroxypropyl methycellulose over the counter non-lipid based artificial tears
OTHERsalineSaline - no brand name

Timeline

Start date
2014-07-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2016-11-04
Last updated
2016-11-04

Source: ClinicalTrials.gov record NCT02956083. Inclusion in this directory is not an endorsement.